logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onPlatformsJoin usTools
 

Apoptosis and Càncer


Research lines

. Molecular mechanisms of apoptosis control.

. Regulation of apoptosis in chronic lymphocytic leukemia.

. Study of the molecular bases of chemo and radioresistance in ovary cancer and gliomes.

. Survival and cell death mechanisms in neuroblastomes.


Mir, R. Tortosa A., Martinez-Soler F.,  Vidal A., Condom E., Perez-Perarnau A., Ruiz-LarroyaT., Gil J., Gimenez-Bonafe P.

Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells

International Journal of Cancer. 2013 Apr 1;132(7):1525-36.

 

Gonzalez-Girones D.M., Moncunill-Massaguer C.,  Iglesias-Serret D., Cosialls, A.M., Perez-Perarnau A., Palmeri C.M., Rubio-Patino C.,  Villunger A., Pons G., Gil J.

AICAR induces Bax/Bak-dependent apoptosis through upregulation of the BH3-only proteins Bim and Noxa in mouse embryonic fibroblasts

Apoptosis. 2013 Aug;18(8):1008-16. doi: 10.1007/s10495-013-0850-6.

 

 

 

Glycogen synthase kinase-3β is involved in ligand-dependent activation of transcription and cellular localization of the glucocorticoid receptor.

Rubio-Patiño C, Palmeri CM, Pérez-Perarnau A, Cosialls AM, Moncunill-Massaguer C, González-Gironès DM, Pons-Hernández L, López JM, Ventura F, Gil J, Pons G, Iglesias-Serret D.

Mol Endocrinol. 2012 Sep;26(9):1508-20.


Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild type ovarian cancer cells.

Mir R, Tortosa A, Martinez-Soler F, Vidal A, Condom E, Pérez-Perarnau A, Ruiz-Larroya T, Gil J, Giménez-Bonafé P.

Int J Cancer. 2012 Sep 10. doi: 10.1002/ijc.27832.


Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells.

Francisco R, Pérez-Perarnau A, Cortés C, Gil J, Tauler A, Ambrosio S.

Cancer Lett. 2012 May 1;318(1):42-52.

 

Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells.

Pérez-Perarnau A, Coll-Mulet L, Rubio-Patiño C, Iglesias-Serret D, Cosialls AM, González-Gironès DM, de Frias M, de Sevilla AF, de la Banda E, Pons G, Gil J.

Epigenetics. 2011 Oct 1;6(10):1228-35.


TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells.

Peña-Rico MA, Calvo-Vidal MN, Villalonga-Planells R, Martínez-Soler F, Giménez-Bonafé P, Navarro-Sabaté À, Tortosa A, Bartrons R, Manzano A.

Radiother Oncol. 2011 Oct;101(1):132-9.

 

Activation of p53 by nutlin-3a induces apoptosis and cellular senescence in human glioblastoma multiforme.

Villalonga-Planells R, Coll-Mulet L, Martínez-Soler F, Castaño E, Acebes JJ, Giménez-Bonafé P, Gil J, Tortosa A.

PLoS One. 2011 Apr 5;6(4):e18588.

 

O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction.

Brell M, Ibáñez J, Tortosa A.

BMC Cancer. 2011 Jan 26;11:35. Review.


AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells.

Santidrián AF, González-Gironès DM, Iglesias-Serret D, Coll-Mulet L, Cosialls AM, de Frias M, Campàs C, González-Barca E, Alonso E, Labi V, Viollet B, Benito A, Pons G, Villunger A, Gil J.

Blood. 2010 Oct 21;116(16):3023-32.


Isoform-selective phosphoinositide 3-kinase inhibitors induce apoptosis in chronic lymphocytic leukaemia cells.

de Frias M, Iglesias-Serret D, Cosialls AM, González-Gironès DM, Pérez-Perarnau A, Rubio-Patiño C, Rückle T, Camps M, de Sevilla AF, de la Banda E, Pons G, Gil J.

Br J Haematol. 2010 Jul;150(1):108-11.

 

Aspirin induces apoptosis in human leukemia cells independently of NF-kappaB and MAPKs through alteration of the Mcl-1/Noxa balance.

Iglesias-Serret D, Piqué M, Barragán M, Cosialls AM, Santidrián AF, González-Gironès DM, Coll-Mulet L, de Frias M, Pons G, Gil J.

Apoptosis. 2010 Feb;15(2):219-29.


Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells.

de Frias M, Iglesias-Serret D, Cosialls AM, Coll-Mulet L, Santidrián AF, González-Gironès DM, de la Banda E, Pons G, Gil J.

Haematologica. 2009 Dec;94(12):1698-707.


Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.

Caja L, Sancho P, Bertran E, Iglesias-Serret D, Gil J, Fabregat I.

Cancer Res. 2009 Oct 1;69(19):7595-602.


Different storing and processing conditions of human lymphocytes do not alter P-glycoprotein rhodamine 123 efflux.

Chiva-Blanch G, Giménez-Bonafe P, Llaudó I, Torras J, Cruzado JM, Petriz J, Castaño E, Franquesa M, Herrero-Fresneda I, Tortosa A, Rama I, Bestard O, Grinyó JM, Lloberas N.

J Pharm Pharm Sci. 2009;12(3):357-66.

 

Overcoming drug resistance by enhancing apoptosis of tumor cells.

Giménez-Bonafé P, Tortosa A, Pérez-Tomás R.

Curr Cancer Drug Targets. 2009 May;9(3):320-40. Review.


Effects of dopamine on LC3-II activation as a marker of autophagy in a neuroblastoma cell model.

Giménez-Xavier P, Francisco R, Santidrián AF, Gil J, Ambrosio S.

Neurotoxicology. 2009 Jul;30(4):658-65.


LC3-I conversion to LC3-II does not necessarily result in complete autophagy.

Giménez-Xavier P, Francisco R, Platini F, Pérez R, Ambrosio S.

Int J Mol Med. 2008 Dec;22(6).

 

Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia.

Coll-Mulet L, Santidrián AF, Cosialls AM, Iglesias-Serret D, de Frias M, Grau J, Menoyo A, González-Barca E, Pons G, Domingo A, Gil J.

Br J Haematol. 2008 Sep;142(5):793-801.

Research group project:


Title: Nuevos Agentes  Proapoptóticos y Redes de Señalización en la  Leucemia Linfocítica Crónica.

Funding entity: PROGRAMA NACIONAL DE BIOMEDICINA. MINISTERIO DE CIENCIA E INNOVACIÓN

Reference / code of award: SAF2010-20519

Length of the project: 2011- 2013


Title: Apoptosis y cáncer

Funding entity: RED TEMATICA DE INVESTIGACIÓN COOPERATIVA DE CANCER. INSTITUTO DE SALUD CARLOS III

Reference / code of award: RD06/0020/0097

Length of the project: 2007-2011 


Title: Grup de Recerca Consolidat “Apoptosi i càncer”.                                                                                                                      

Funding entity: AGAUR (DURSI, Generalitat de Catalunya)

Reference / code of award: 2009SGR00395

Length of the project: 2009 - 2013


Title: Development of proapoptotic bisthiazoles as anticancer agents

Funding entity: Fundació Bosch i Gimpera

Reference / code of award: PPV022-08

Length of the project: 2009 - 2011

imatge personal
 

Group leader

Joan Gil
Telephone  
+34 934029095
E-mail  
jgil@idibell.cat
 
© 2017 Institut d'Investigació Biomèdica de Bellvitge



Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




Encara no heu contestat l'enquesta de satisfacció sobre la píndola formativa sobre patents. No trigareu més de cinc minuts a fer-ho. La vostra opinió és molt important per millorar l’IDIBELL.

Voleu fer l’enquesta ara?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No





Please, remember to introduce your holiday’s planning in the application

Accept

Cancell